Hartford Great Health Overview
Latest ROE for Hartford Great Health: 144.6% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow144.60%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for HFUS is 144.6%. That is above the Consumer Discretionary sector average of 23.23%. Investors often review this figure alongside Hartford Great Health's historical trend and sector peers before judging valuation or financial health.
Against Consumer Discretionary companies, HFUS currently prints 144.6% for ROE, while the sector average sits near 23.23%. That is roughly 522.5% above the sector mean. Large gaps often invite a closer look at Hartford Great Health's growth, margins, and balance sheet.
Return on Equity shows how effectively Hartford Great Health converts resources into returns. At 144.6%, HFUS may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting HFUS's ROE (144.6%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Hartford Great Health's ROE against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.
